S2 Ep13: #24 Treating OUD in the Fentanyl Era: ASAM Treatment Week with Dr. Melissa Weimer
Oct 17, 2023
auto_awesome
Dr. Melissa Weimer from Yale University discusses treating opioid use disorder in the fentanyl era. Topics include methadone and buprenorphine initiation changes, pitfalls, precipitated withdrawal, dosing strategies, and individualized care. Learn how to provide person-centered care and address challenges in addiction medicine.
Initiating methadone and buprenorphine safely in the fentanyl era is crucial for treating opioid use disorder.
Differentiating and treating buprenorphine precipitated withdrawal effectively is essential for individualized care.
Deep dives
Introduction and Halloween Plans
The podcast episode opens with the hosts expressing excitement about National Addiction Treatment Week and sharing their Halloween plans. They discuss dressing up their kids, one as Elvis due to long hair, and another as a clarinet-playing raptor. They mention dressing up as Harry Potter and the challenges of finding a wand. The hosts banter about Tabata workouts and share their Halloween traditions.
Discussion on Addiction Treatment
The episode delves into the treatment of opioid use disorder in the era of high potency synthetic opioids like fentanyl. Dr. Melissa Weimer joins as a guest to discuss initiating treatments like methadone and buprenorphine for individuals using fentanyl. The importance of demystifying addiction medicine topics, reducing stigma, and advocating for individuals using substances is emphasized.
National Addiction Treatment Week
The hosts highlight the significance of National Addiction Treatment Week, emphasizing that addiction is a treatable chronic disease with evidence-based treatments. They encourage combating stigma and promoting awareness about available treatments. The discussion includes the benefits of addiction medicine fellowship programs and board certification in addiction medicine.
Addressing Buprenorphine Precipitated Withdrawal
The hosts address the challenges of buprenorphine precipitated withdrawal in individuals with exposure to high potency synthetic opioids like fentanyl. Dr. Weimer discusses strategies to differentiate true precipitated withdrawal from insufficient withdrawal treatment. The importance of individualized treatment approaches and higher starting doses of buprenorphine is highlighted.
Keep saving lives by prescribing methadone and buprenorphine. Learn how initiations of each have changed in the era of high-potency synthetic opioids (HPSOs) like fentanyl and how to continue to provide person-centered care to people with opioid use disorder. We’re joined by Dr Melissa Weimer, @DrMelissaWeimer (Yale University). This episode is in honor of National Addiction Treatment Week (treataddictionsavelives.org).
Claim CME for this episode at curbsiders.vcuhealth.org!
By listening to this episode and completing CME, this can be used to count towards the new DEA 8-hr requirement on substance use disorders education.